From the Department of Pathology and Division of Medical Oncology, University of Colorado, Aurora (Dr Boyle); the Department of Pathology & Microbiology, University of Nebraska Medical Center, Omaha (Dr Bridge); Roswell Park Cancer Institute, Buffalo, New York (Dr Sabatini); the Department of Pathology and Laboratory Medicine, North Shore University Health System, Evanston, Illinois (Dr Nowak); the College of American Pathologists, Northfield, Illinois (Ms Vasalos); Pathology and Laboratory Medicine, Northwestern University Feinberg School of Medicine, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois (Dr Jennings); and the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota (Dr Halling). Dr Sabatini is now with Molecular Diagnostics, North Shore University Health System, Evanston, Illinois.
Arch Pathol Lab Med. 2014 Mar;138(3):363-70. doi: 10.5858/arpa.2013-0159-CP.
The College of American Pathologists surveys are the largest laboratory peer comparison programs in the world. These programs allow laboratories to regularly evaluate their performance and improve the accuracy of the patient test results they provide. Proficiency testing is offered twice a year to laboratories performing microsatellite instability testing. These surveys are designed to emulate clinical practice, and some surveys have more challenging cases to encourage the refinement of laboratory practices.
This report summarizes the results and trends in microsatellite instability proficiency testing from participating laboratories from the inception of the program in 2005 through 2012.
We compiled and analyzed data for 16 surveys of microsatellite instability proficiency testing during 2005 to 2012.
The number of laboratories participating in the microsatellite instability survey has more than doubled from 42 to 104 during the 8 years analyzed. An average of 95.4% of the laboratories correctly classified each of the survey test samples from the 2005A through 2012B proficiency challenges. In the 2011B survey, a lower percentage of laboratories (78.4%) correctly classified the specimen, possibly because of overlooking subtle changes of microsatellite instability and/or failing to enrich the tumor content of the specimen to meet the limit of detection of their assay.
In general, laboratories performed well in microsatellite instability testing. This testing will continue to be important in screening patients with colorectal and other cancers for Lynch syndrome and guiding the management of patients with sporadic colorectal cancer.
美国病理学家学院的调查是世界上最大的实验室同行比较项目。这些项目使实验室能够定期评估其性能,并提高其提供的患者测试结果的准确性。每年进行两次微卫星不稳定性测试实验室的能力验证测试。这些调查旨在模拟临床实践,有些调查具有更具挑战性的病例,以鼓励实验室实践的改进。
本报告总结了 2005 年至 2012 年参与该计划的实验室的微卫星不稳定性能力验证测试的结果和趋势。
我们编译并分析了 2005 年至 2012 年期间 16 次微卫星不稳定性能力验证测试的数据。
在分析的 8 年内,参加微卫星不稳定性调查的实验室数量从 42 家增加到 104 家,增加了一倍多。2005A 至 2012B 能力挑战中,平均有 95.4%的实验室正确分类了每个调查测试样本。在 2011B 调查中,较少的实验室(78.4%)正确分类了标本,可能是因为忽略了微卫星不稳定性的细微变化,或未能使标本的肿瘤含量富集到其检测方法的检测限。
总的来说,实验室在微卫星不稳定性检测中表现良好。这种检测将继续在筛查结直肠癌和其他癌症患者的林奇综合征以及指导散发性结直肠癌患者的治疗中发挥重要作用。